Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke
- 21 October 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 113 (Pt A) , 109315
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The synergetic effect of edaravone and borneol in the rat model of ischemic strokeEuropean Journal of Pharmacology, 2014
- NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic StrokeJournal of Cerebral Blood Flow & Metabolism, 2014
- Borneol, a Bicyclic Monoterpene Alcohol, Reduces Nociceptive Behavior and Inflammatory Response in MiceThe Scientific World Journal, 2013
- II. Cerebral Infarction/Transient Ischemic Attack (TIA)Journal of Stroke and Cerebrovascular Diseases, 2011
- Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathwayNeuroscience, 2011
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- Edaravone Attenuates Brain Edema and Neurologic Deficits in a Rat Model of Acute Intracerebral HemorrhageStroke, 2008
- Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses After Transient Focal Ischemia in Mice BrainStroke, 2005
- Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain InfarctionCerebrovascular Diseases, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001